Pharmaceutical & Healthcare

Pharmaceutical & Healthcare

The global pharmaceutical market was worth $996bn in 2017, up almost 3% on the year before. The US accounted for 45% of that total, or $453bn. Europe contributed a further 21% (or $214bn), and the rest of the established world for 11% (or $112bn). The fastest growth continues to come from emerging markets, where sales rose by almost 8% in 2017 to $216bn. The top five markets by value are the US, Japan, China, Germany and France. Drug development has slowed dramatically as a result of rising costs. Despite a total R&D budget of $154bn in 2016, only 22 new drugs were approved by the US FDA in 2016, fewer than half the year before.

The World's Leading Pharma Companies in 2017 by healthcare revenues

 Johnson & Johnson  AbbVie
 Roche  Gilead Sciences
 Pfizer  Eli Lilly & Co
 Novartis  Amgen
 Sanofi  AstraZeneca
 Merck & Co  Teva
 Glaxo SmithKline  Bristol-Myers Squibb
 Bayer  Abbott Laboratories

Source: company reports

The World's Top 20 Prescription Drugs in 2015 by global sales

Humira $14.02bn AbbVie Crestor $5.43bn AstraZeneca / Shionogi
Harvoni $13.86bn Gilead Sciences Solvadi $5.28bn Gilead Sciences
Enbrel $9.03bn Amgen / Pfizer / Takeda Seretide / Advair $5.23bn GlaxoSmithKline
Remicade $8.96bn J&J / Merck / Mitsubishi Tanabe Copaxone $5.21bn Teva
Lantus $7.21bn Sanofi Neulasta $4.72bn Amgen
Avastin $6.91bn Roche Gleevec $4.66bn Novartis
Herceptin $6.75bn Roche Xarelto $4.41bn Bayer/ J&J
Prevnar $6.25bn Pfizer Spiriva $3.94bn Boehringer Ingelheim
Rituxan / MabThera $5.83bn Roche Januvia $3.86bn Merck
Revlimid $5.80bn Celgene Lyrica $3.66bn Pfizer / Eisai

Source: Igea, company reports

The World's Top Consumer Healthcare Companies in 2014

 GlaxoSmithKline / Novartis   Reckitt Benckiser
 Bayer / Merck  Boehringer Ingelheim
 Johnson & Johnson  Procter & Gamble
 Sanofi  Taisho
 Pfizer  Takeda Pharmaceutical

Source: Bayer

The World's Top Animal Healthcare Companies in 2014

 Zoetis (ex-Pfizer) 20% global share  Merial (Sanofi) 12%
 Elanco/Novartis AH (Eli Lilly & Co) 15%  Bayer 7%
 Merck & Co 14%  Boehringer Ingelheim 6%

Source: PwC

Top US OTC Products in 2013 by sales

Advil (Pfizer) $615m Alcon (Novartis) $447m Dr Scholl's (Merck*) $370m
Nature Made $596m Claritin (Merck*) $430m Aleve (Bayer) $364m
Mucinex (Reckitt) $578m Depend (Kimberly-Clark) $393m Prilosec OTC (P&G) $359m
Ensure (Abbott) $496m Poise (Kimberly-Clark) $379m 5 Hour Energy $332m

* Bayer from 2014. Source: Main products including biggest variants; IRI 52 wks to Jan 2014 all channels, Drugstorenews

Other companies profiled in Adbrands

 Abbott Laboratories  Allergan
 Valeant  Takeda
 Astellas Pharma  

Gone But Not (Completely) Forgotten

 Warner-Lambert  Smithkline Beecham
 Wyeth  Aventis
 Schering-Plough  Pharmacia

All rights reserved © Mind Advertising Ltd 1998-2018